EUVIMEDEUVIMED entdecken
Kohortenstudie

Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?

Maeva Cotinat iD, Christoph Heesen iD, Ines Boudiaf iD, Christian Lederer, Martin Daumer, Adil Maarouf iD, Laurent Bensoussan, Jean-Philippe Ranjeva iD, Jan-Patrick Stellmann

Multiple Sclerosis Journal · 2026-11 · 32 (13) · 1460-1470

DOI: 10.1177/13524585261476543 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 17.08.2026. Verfasst von Maeva Cotinat und 8 weiteren Autor:innen. Beteiligte Einrichtung: CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; P…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Chronic Progressive, Disease Progression, Walking Speed. Die Arbeit nennt 34 Literaturangaben. Gefördert von: France Life Imaging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary progressive multiple sclerosis (PPMS) involves gradual disability accumulation driven by neurodegeneration. Standard outcomes, including the Expanded Disability Status Scale (EDSS) and timed 25-foot walk (T25FW), lack sensitivity to subtle functional changes. Real-life walking speed (RWS) measured with wearable sensors may offer a more responsive marker of progression.

Objectives

In a prospective cohort (2012–2022) at the University Medical Center Hamburg-Eppendorf, adults with PPMS (18–65 years, EDSS ⩽7.0) underwent repeated EDSS, T25FW, Nine-Hole Peg Test (9HPT), and Symbol Digit Modalities Test (SDMT). RWS was recorded using an accelerometer. Disease progression was defined as ⩾20% worsening in T25FW/9HPT, ⩾8-point SDMT decline, EDSS increase (⩾1.0 or ⩾0.5 if >5), or RWS reduction >0.08 m/s.

Results

Among 110 participants (mean age: 52 years; baseline EDSS: 3.5) followed for a median of 3 years, RWS showed a symmetric distribution and declined steadily with increasing EDSS, unlike the skewed T25FW distribution. Annual progression was detected in >30% of participants using RWS, compared with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Sclerosis, Chronic ProgressiveDisease ProgressionWalking SpeedHumansMiddle AgedFemaleAdultMaleProspective StudiesDisability EvaluationAgedYoung AdultAccelerometry

Stichwörter der Autor:innen

Primary progressive multiple sclerosiscohort studydisease progressionoutcome measurementprogressivereal-life walking speed

Autor:innen und Institutionen

  • CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; Physical and Rehabilitation Medicine Department, Hôpitaux Sud, APHM, Ai…
  • Institut für Neuroimmunologie und Multiple Sklerose, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sylvia Lawry Centre for Multiple Sclerosis Research, Human Motion Institute, Munich, Germany.
  • Sylvia Lawry Centre for Multiple Sclerosis Research, Human Motion Institute, Munich, Germany; Trium Analysis Online GmbH, Research, Munich, Germany.
  • CRMBM, CNRS, Aix Marseille University, Marseille, France; CEMEREM, Hôpital Universitaire Timone, APHM, Aix Marseille University, Marseille, France; Service de Neurologie, Pôle de Neurosciences Cliniques, Hôpital de la T…
  • Physical and Rehabilitation Medicine Department, Aix Marseille University, APHM, INT, Hôpitaux Sud, Marseille, France; Physical and Rehabilitation Medicine Department, UGECAM Provence-Alpes-Cote d'Azur, Marseille, Franc…

ORCID-Profile: Maeva Cotinat, Christoph Heesen, Ines Boudiaf, Adil Maarouf, Jean-Philippe Ranjeva

Förderung

  • France Life Imaging

Zitieren

APA

Cotinat, M., Heesen, C., Boudiaf, I., Lederer, C., Daumer, M., Maarouf, A., Bensoussan, L., Ranjeva, J. P., & Stellmann, J. P. (2026). Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?. Multiple Sclerosis Journal, 32(13), 1460-1470. https://doi.org/10.1177/13524585261476543

Vancouver

Cotinat M, Heesen C, Boudiaf I, Lederer C, Daumer M, Maarouf A, et al. Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?. Multiple Sclerosis Journal. 2026;32(13):1460-1470. doi:10.1177/13524585261476543

BibTeX
@article{Cotinat2026,
  author = {Cotinat, Maeva and Heesen, Christoph and Boudiaf, Ines and Lederer, Christian and Daumer, Martin and Maarouf, Adil and Bensoussan, Laurent and Ranjeva, Jean-Philippe and Stellmann, Jan-Patrick},
  title = {Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?},
  journal = {Multiple Sclerosis Journal},
  year = {2026},
  volume = {32},
  number = {13},
  pages = {1460--1470},
  doi = {10.1177/13524585261476543}
}
Kostenlos starten →